Insurance company denies covering medication for condition that ‘could kill’ med student, she says

Spread the love

Malik JacksonUpdated: Dec 13, 2024 / 10:11 AM CST

KANSAS CITY, Mo. (WDAF) — Blue Cross and Blue Shield of Kansas City denied coverage of a medicine that a Missouri woman says could save her life, leaving her with a monthly bill of over $8,000.

“I was at risk for spontaneous internal bleeding that could kill me,” Kaitlyn Sy said.

Sy, a University of Kansas medical student, said she’s fighting back just weeks after a near-death experience. She’s been forced to pause her medical studies while waiting for this medicine to be approved, compromising her already weak immune system.

Sy conducted her interview with Nexstar’s WDAF over Zoom, unable to do it in person because of her condition.

Sy has dreamed of becoming a doctor since middle school, “whether that be bringing hope and healing to fellow humans, intellectual stimulating work of diagnosing and treating diseases, being involved in medical research.”Luigi Mangione was reported missing 2 weeks before CEO slain: police 

But three years ago, doctors diagnosed her with an autoimmune disease that mistakenly attacks the platelets in her blood cells.

When she bleeds, there’s nothing to clot those cells. Sy says that could cause life-threatening bleeding. For years, no treatment worked well for her.

Just weeks ago, that scenario happened: Sy was forced to go to the ER to treat internal bleeding. Her hematologist had one more option, a pill called Promacta that could stabilize this issue. Things changed when Sy got to the pharmacy.

“The pharmacy tech — her eyebrows go up — and I said, ‘This can’t be good.’ And she says, ‘This medication is going to cost you over $8,000.’”

Sy said she can’t afford to pay the bill every month. She called her insurance company, and they stood by the denial.

WDAF asked her provider, Blue Cross and Blue Shield of Kansas City, about the denial, but was told that the company could not comment on the matter.

“At Blue Cross and Blue Shield of Kansas City (Blue KC), we are committed to the health and wellness of our members,” reads the company’s statement, in part. “Two of our primary responsibilities are to safeguard our members’ health information and protect their privacy. Because of this, we cannot talk about the specifics of this, or any other, case.”

As of today, Sy is still without the meds her doctor prescribed. But she knows she’s not alone in her situation, so for the sake of the people who have no one to fight for them, she says she will refuse to be silent.

“There are thousands if not millions of other people who are suffering due to being denied and delayed this medically necessary treatment and I feel … I owe it to these patients to use my voice to make their voices heard,” she said. Read More At News Nation!

Related Posts

Exploring Alternative Cancer Treatments: From Ivermectin to Nanorobots!

Spread the love

Spread the love In the quest to combat cancer, a disease that remains one of the leading causes of death worldwide, the medical community continually seeks innovative and alternative treatments. Here’s an overview of several unconventional approaches currently under investigation or discussion: Ivermectin and FenbendazoleIvermectin, traditionally an antiparasitic drug, has been studied for its potential antitumor effects. Research has shown that it can inhibit cancer cell proliferation, induce apoptosis, and modulate pathways like EGFR/ERK/Akt/NF-κB, potentially reversing drug resistance in cancer cells. Similarly, fenbendazole, another antiparasitic, has garnered attention for its potential in cancer treatment. There are anecdotal reports and some preclinical studies suggesting it might inhibit cancer cell growth. Both drugs have been part of protocols like the Joe Tippens Protocol, where they are combined with other supplements and dietary changes, showing some promise in case studies. Tata Institute’s Breakthrough in Cancer Drug DevelopmentThe Tata Institute has been at the forefront of cancer research, developing innovative drugs. One notable breakthrough involves targeting cancer cell metabolism with drugs that can selectively kill cancer cells while sparing healthy ones. Although specific details on the drug are sparse due to ongoing research, this approach aims at disrupting cancer’s energy supply, a novel strategy in cancer therapy. Small Extracellular Vesicles (sEVs)Small extracellular vesicles are nanometer-sized vesicles released by cells that can transfer molecular information between cells, including from cancer cells to healthy ones, influencing tumor progression. Research into sEVs focuses on their potential as biomarkers for early cancer detection and as carriers for therapeutic…

“Powering the Future, One Chip at a Time” ~ Revolutionize Your Technology with the SUPER INTEGRATED CIRCUIT CHIP SEMICONDUCTOR DEVICE!

Spread the love

Spread the love Discover the future of electronics with our SUPER INTEGRATED CIRCUIT CHIP SEMICONDUCTOR DEVICE (Heterodiamond) Chip. Unmatched Performance: Experience speed and efficiency like never before. Our Heterodiamond chips handle complex computations with ease, pushing the boundaries of what’s possible in electronics.Miniaturization Mastery: Smaller, yet more powerful. Our chips pack immense functionality into a space that was once unimaginable, allowing for sleeker, more advanced devices.Energy Efficiency: With lower power consumption, extend battery life or reduce energy costs dramatically, making your devices eco-friendlier and cost-effective.Versatile Applications: From cutting-edge smartphones to autonomous vehicles, from smart homes to industrial automation, our Heterodiamond chips are at the heart of innovation. Features: * Wider Band Gap Than Diamond! * High-Density Integration: More transistors in less space mean more capabilities without increasing size. * superior radiation hardness * Better Heat resistance * Electromagnetic shielding * Resistance to damage from harsh elements and environments * Advanced Manufacturing: Using the latest in photolithography and materials science, we ensure reliability and performance. * Future-Proof Technology: Designed with scalability in mind, our chips are ready for tomorrow’s demands today. Engineers and Innovators: Integrate the future into your designs. Contact us for samples or technical specifications.Consumers: Look for products with our Heterodiamond chips to guarantee you’re using the forefront of technology. Join the electronics revolution. Our SUPER INTEGRATED CIRCUIT CHIP SEMICONDUCTOR DEVICE is not just a component; they’re the foundation for the next generation of technology. Contact Us: Email ~ Chicago Pixels at admin@chicagopixels.net Or Call ~ 312-513-7949

One thought on “Insurance company denies covering medication for condition that ‘could kill’ med student, she says

  1. Hi, i think thgat i saw youu vosited my weblig sso i came too
    “return the favor”.I’m tryingg to ffind tings too enhance my webb site!I suppose itts okk to usee a
    few of yor ideas!!

Leave a Reply

Your email address will not be published. Required fields are marked *